Tocilizumab for critically ill patients with refractory anti-NMDAR encephalitis: a case report
BackgroundAnti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis often requires intensive care and rapid escalation of immunotherapy. We report a critically ill woman with refractory anti-NMDAR encephalitis treated with tocilizumab (TCZ) as early…